Hydrocortisone and vasopressor-resistant shock in preterm neonates

Pediatrics

Volumn 117, Issue 2, 2006, Pages 516-518

  Seri, Istvan ^a,b,c  

^a WOMEN S AND CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; HYDROCORTISONE; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR; CARDIOTONIC AGENT; VASOCONSTRICTOR AGENT;

BRAIN DEVELOPMENT; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG POTENTIATION; DRUG SAFETY; HUMAN; HYPERGLYCEMIA; HYPOTENSION; INFECTION; INTESTINE PERFORATION; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NOTE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; NEWBORN; SHOCK; VERY LOW BIRTH WEIGHT;

CARDIOTONIC AGENTS; HUMANS; HYDROCORTISONE; HYPOTENSION; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; SHOCK; VASOCONSTRICTOR AGENTS;

EID: 33644851632     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2057     Document Type: Note

References (13)

1. Helbock HJ, Insoft RM, Conte FA. Glucocorticoid-responsive hypotension in extremely low birth weight newborns. Pediatrics. 1993;92:715-717
2. Ng PC, Lam CWK, Fok TF, Lee HC, Ma KC, Chan HIS. Refractory hypotension in preterm infants with adrenocortical insufficiency. Arch Dis Child Fetal Neonatal Ed. 2001;84:F122-F124
3. Seri I, Tan R, Evans J. Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics. 2001;107:1070-1077
4. Ng PC, Lee CH, Liu F, et al. A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics. 2006;117:367-375
5. Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitization of beta-adrenergic receptors [published correction appears in FASEB J. 1990;4:3049]. FASEB J. 1990;4:2881-2890
6. Wehling M. Specific, non-genomic actions of steroid hormones. Annu Rev Physiol. 1997;59:365-393
7. Ng PC, Lee HC, Lam CWK, et al. Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birth weight infants. Arch Dis Child Fetal Neonatal Ed. 2004;89:F119-F116
8. Watterberg KL, Gerdes JS, Cole CH, et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics. 2004;114:1649-1657
9. Hamrahian AH, Oseni TS, Arafah BM. Measurements of free cortisol in critically ill patients. N Eng J Med. 2004;350:1629-1638
10. Baud O. Postnatal steroid treatment and brain development. Arch Dis Child Fetal Neonatal Ed. 2004;89:F96-F100
11. Lodygensky GA, Rademaker K, Szimine S, et al. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics. 2005;116:1-7
12. Peltoniemi O, Kari MA, Heinonen K, et al. Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants. J Pediatr. 2005;146:632-637
13. Noori S, Wong P, Friedlich P, Garingo A, Seri I. Hemodynamic Changes in Response to Hydrocortisone in Pressor-Treated Neonates [abstract]. Presented at: American Pediatric Society/Society for Pediatric Research; Washington, DC; May 17, 2005; Abstract 581